All entries for: Corcept Therapeutics Inc

April 30, 2026

Corcept Therapeutics Inc

Neutral Outlook

The current Trump administration is pursuing policies to reduce regulations and expenditures across government including at the HHS, the FDA, CMS and related agencies. These actions, presently directed by executive orders or memoranda from the Office of Management and Budget, may propose policy changes that create additional uncertainty for our business.

Scroll to Top